Vergent Bioscience
Developer of molecular imaging probes designed for the diagnosis and removal of cancer cells. The company develops molecularly-targeted probes that bind to enzymes that are over-expressed in tumor tis...
Valuation
$75M
Market implied
Share Price
N/A
Total Raised
$56.4M
Last Round
N/A